Regulatory Update: Philippines’ FDA Publishes New Guideline on Prepackaged Processed Food Products Containing Trans-Fatty Acids (TFA)

Philippines: On 27 October 2022 Food and Drug Administration published updated guidelines on prepackaged processed food products containing industrially produced trans-fatty acids (IPTFA) amending FDA Circular 2021-028 entitled “Guidelines for Prepackaged Processed Food Products Containing Trans-Fatty Acids (TFA)”

The following Sections of FDA Circular 2021-028 are hereby amended, as follows:

V. GENERAL GUIDELINES

B. The manufacture, trading, importation, distribution, and sale of the following shall be prohibited:

  1. Partially Hydrogenated Oil (PHO) to be consumed alone or used in the preparation of processed food products;
  2. Oils and fats made blended with PHO; and
  3. Prepackaged processed food with PHO and industrially – produced TFAcontent of more than 2g per 100g or mL.

VI. SPECIFIC GUIDELINES

F. As appropriate, ‘oil’ together with either the term ‘vegetable’ or ‘animal’, qualified by the term ‘hydrogenated’ or ‘partially hydrogenated’, shall be declared in the data entry for ingredient listing and on the label.

G. After the transition period, prepackaged processed food products formulation shall not contain PHO, oils and fats blended with PHOs, and industrially producedTFA beyond the specified limits.

VIII. TRANSITORY PROVISIONS

The following shall be added:

During the transition period, food products covered in Section V.B.1 to 3 with valid Certificate of Product Registration (CPR) shall be applied for initial CPR complying with the provisions of this Circular. Applications for renewal or amendment of CPRs of such products shall be denied.

References

Republic of the Philippines Department of Health Food and Drug Administration. (2022). Updated Guidelines on Prepackaged Processed Food Products Containing Industrially Produced Trans-Fatty Acids (IPTFA) amending FDA Circular 2021-028 entitled “Guidelines for Prepackaged Processed Food Products Containing Trans-Fatty Acids (TFA)” (FDA Circular No. 2021-028-A).